Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Carbone

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2023
HMGB1 released by mesothelial cells drives the development of asbestos-induced mesotheliomaJoelle S Suarez, Flavia Novelli, Keisuke Goto, et al.
International Journal of Cancer|September 11, 2010
Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapyJedd M Hillegass, Steven R Blumen, Kai Cheng, et al.
CA: a Cancer Journal for Clinicians|July 9, 2019
Mesothelioma: Scientific clues for prevention, diagnosis, and therapyMichele Carbone, Prasad S Adusumilli, H Richard Alexander, et al.
Nature|June 15, 2017
BAP1 regulates IP3R3-mediated Ca<sup>2+</sup> flux to mitochondria suppressing cell transformationAngela Bononi, Carlotta Giorgi, Simone Patergnani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2020
Heterozygous germline <i>BLM</i> mutations increase susceptibility to asbestos and mesotheliomaAngela Bononi, Keisuke Goto, Guntulu Ak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2019
Pathologic Considerations and Standardization in Mesothelioma Clinical TrialsMing-Sound Tsao, Michele Carbone, Francoise Galateau-Salle, et al.
Nature Reviews. Cancer|May 31, 2020
Tumour predisposition and cancer syndromes as models to study gene-environment interactionsMichele Carbone, Sarah T Arron, Bruce Beutler, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2023
BAP1 is a novel regulator of HIF-1αAngela Bononi, Qian Wang, Alicia A Zolondick, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2016
Consensus Report of the 2015 Weinman International Conference on MesotheliomaMichele Carbone, Shreya Kanodia, Ann Chao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2025
Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of DiseaseXinwei Wu, Frank Villa Hernandez, Haitao Wang, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2023
HMGB1 released by mesothelial cells drives the development of asbestos-induced mesotheliomaJoelle S Suarez, Flavia Novelli, Keisuke Goto, et al.
International Journal of Cancer|September 11, 2010
Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapyJedd M Hillegass, Steven R Blumen, Kai Cheng, et al.
CA: a Cancer Journal for Clinicians|July 9, 2019
Mesothelioma: Scientific clues for prevention, diagnosis, and therapyMichele Carbone, Prasad S Adusumilli, H Richard Alexander, et al.
Nature|June 15, 2017
BAP1 regulates IP3R3-mediated Ca<sup>2+</sup> flux to mitochondria suppressing cell transformationAngela Bononi, Carlotta Giorgi, Simone Patergnani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2020
Heterozygous germline <i>BLM</i> mutations increase susceptibility to asbestos and mesotheliomaAngela Bononi, Keisuke Goto, Guntulu Ak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2019
Pathologic Considerations and Standardization in Mesothelioma Clinical TrialsMing-Sound Tsao, Michele Carbone, Francoise Galateau-Salle, et al.
Nature Reviews. Cancer|May 31, 2020
Tumour predisposition and cancer syndromes as models to study gene-environment interactionsMichele Carbone, Sarah T Arron, Bruce Beutler, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2023
BAP1 is a novel regulator of HIF-1αAngela Bononi, Qian Wang, Alicia A Zolondick, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2016
Consensus Report of the 2015 Weinman International Conference on MesotheliomaMichele Carbone, Shreya Kanodia, Ann Chao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2025
Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of DiseaseXinwei Wu, Frank Villa Hernandez, Haitao Wang, et al.
Pageof 17